Moreover, we demonstrated that SOX2 feedback inhibits FOXO3a expression by directly transactivating DNMT1, and inhibition of DNMT activity suppressed tumor growth via regulation of FOXO3a/FOXM1/SOX2 signaling in breast cancer. This evidence concerns the gene FOXM1 and breast carcinoma.